Xiao Ke Qing improves glycometabolism and ameliorates insulin resistance by regulating the PI3K/Akt pathway in KKAy mice.
Saved in:
| Title: | Xiao Ke Qing improves glycometabolism and ameliorates insulin resistance by regulating the PI3K/Akt pathway in KKAy mice. |
|---|---|
| Authors: | Li X; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China., Li X; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China. lixx@tasly.com., Wang G; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China., Xu Y; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China., Wang Y; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China., Hao R; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China., Ma X; Department of Pharmacology and Toxicology, Tasly Pharmaceutical Co., Ltd., Tianjin, 300410, China. |
| Source: | Frontiers of medicine [Front Med] 2018 Dec; Vol. 12 (6), pp. 688-696. Date of Electronic Publication: 2018 Nov 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Higher Education Press Country of Publication: China NLM ID: 101549428 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2095-0225 (Electronic) Linking ISSN: 20950217 NLM ISO Abbreviation: Front Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
